25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BCDA (Biocardia) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biocardia together

I guess you are interested in Biocardia Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Biocardia’s Financial Insights
  • 📈 Technical Analysis (TA) – Biocardia’s Price Targets

I'm going to help you getting a better view of Biocardia Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biocardia Inc

I send you an email if I find something interesting about Biocardia Inc.

1. Quick Overview

1.1. Quick analysis of Biocardia (30 sec.)










1.2. What can you expect buying and holding a share of Biocardia? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.28
Expected worth in 1 year
$-0.14
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$0.14
Return On Investment
5.8%

For what price can you sell your share?

Current Price per Share
$2.39
Expected price per share
$1.95 - $2.92
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biocardia (5 min.)




Live pricePrice per Share (EOD)
$2.39
Intrinsic Value Per Share
$-16.93 - $-0.20
Total Value Per Share
$-17.21 - $-0.48

2.2. Growth of Biocardia (5 min.)




Is Biocardia growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.5m-$725.7k$753k2,763.3%

How much money is Biocardia making?

Current yearPrevious yearGrowGrow %
Making money-$2m-$2.5m$486.5k23.2%
Net Profit Margin-12,727.0%-7,186.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biocardia (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#775 / 872

Most Revenue
#865 / 872

Most Profit
#302 / 872

Most Efficient
#830 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biocardia?

Welcome investor! Biocardia's management wants to use your money to grow the business. In return you get a share of Biocardia.

First you should know what it really means to hold a share of Biocardia. And how you can make/lose money.

Speculation

The Price per Share of Biocardia is $2.39. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biocardia.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biocardia, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.28. Based on the TTM, the Book Value Change Per Share is $0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biocardia.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.50-20.8%-0.38-16.1%-0.47-19.8%-0.47-19.7%-0.52-21.9%-0.46-19.2%
Usd Book Value Change Per Share-0.43-18.1%0.031.4%-0.19-8.0%-0.14-5.7%0.00-0.1%-0.06-2.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.43-18.1%0.031.4%-0.19-8.0%-0.14-5.7%0.00-0.1%-0.06-2.5%
Usd Price Per Share2.54-2.70-1.04-1.87-2.30-2.01-
Price to Earnings Ratio-1.28--1.87--0.49--1.07--1.14-3,153.92-
Price-to-Total Gains Ratio-5.88-10.78--15.78--2.14--4.38--3.21-
Price to Book Ratio-9.11-0.75-0.53-1.40-1.45-71.85-
Price-to-Total Gains Ratio-5.88-10.78--15.78--2.14--4.38--3.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.39
Number of shares418
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.00
Usd Total Gains Per Share0.030.00
Gains per Quarter (418 shares)14.47-0.91
Gains per Year (418 shares)57.88-3.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1058480-4-14
201161060-7-18
301741640-11-22
402322220-15-26
502892800-18-30
603473380-22-34
704053960-25-38
804634540-29-42
905215120-33-46
1005795700-36-50

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%6.034.00.015.0%18.094.03.015.7%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%11.028.01.027.5%33.079.03.028.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%2.00.0113.01.7%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%11.028.01.027.5%33.079.03.028.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biocardia Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.4320.035-1349%-0.191-56%-0.136-69%-0.002-99%-0.059-86%
Book Value Per Share---0.2790.005-5678%-0.133-52%0.227-223%1.016-127%1.289-122%
Current Ratio--0.3630.915-60%0.659-45%1.229-70%2.227-84%159.624-100%
Debt To Asset Ratio--1.7021.179+44%1.327+28%1.018+67%0.741+130%0.540+215%
Debt To Equity Ratio---1.181-100%0.727-100%1.108-100%0.886-100%0.721-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--11112578.60013418874.475-17%3057574.537+263%9514711.646+17%16096306.892-31%992043058.512-99%
Eps---0.497-0.385-23%-0.474-5%-0.471-5%-0.524+5%-0.460-8%
Free Cash Flow Per Share---0.297-0.372+25%-0.410+38%-0.418+41%-0.460+55%-0.401+35%
Free Cash Flow To Equity Per Share---0.2610.000-1879215175209093632%-0.179-31%-0.137-47%0.010-2758%-0.031-88%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0050%
Intrinsic Value_10Y_max---0.204----------
Intrinsic Value_10Y_min---16.934----------
Intrinsic Value_1Y_max---1.376----------
Intrinsic Value_1Y_min---1.686----------
Intrinsic Value_3Y_max---3.101----------
Intrinsic Value_3Y_min---5.105----------
Intrinsic Value_5Y_max---3.581----------
Intrinsic Value_5Y_min---8.541----------
Market Cap13031690.100-6%13849578.60014735624.475-6%5685824.537+144%10183211.646+36%12541256.892+10%985757208.512-99%
Net Profit Margin----127.2700%-71.8600%-74.7260%-71.2420%-45.1660%
Operating Margin----127.4120%-74.4650%-75.8500%-72.2330%-45.7420%
Operating Ratio---136.022-100%74.449-100%88.592-100%96.065-100%60.037-100%
Pb Ratio-8.573+6%-9.1120.753-1310%0.529-1821%1.401-750%1.454-727%71.845-113%
Pe Ratio-1.201+6%-1.277-1.870+46%-0.493-61%-1.067-16%-1.142-11%3153.921-100%
Price Per Share2.390-6%2.5402.703-6%1.043+144%1.868+36%2.300+10%2.006+27%
Price To Free Cash Flow Ratio-2.014+6%-2.140-2.000-7%-0.562-74%-1.190-44%-1.316-38%155.689-101%
Price To Total Gains Ratio-5.529+6%-5.87610.776-155%-15.775+168%-2.140-64%-4.382-25%-3.212-45%
Quick Ratio--0.2930.851-66%0.594-51%1.160-75%2.153-86%200.010-100%
Return On Assets---1.252-0.679-46%-0.691-45%-0.569-55%-0.429-66%-0.392-69%
Return On Equity----0.8440%-0.5240%-0.7540%-0.6000%-0.5790%
Total Gains Per Share---0.4320.035-1349%-0.191-56%-0.136-69%-0.002-99%-0.059-86%
Usd Book Value---1520000.00027250.000-5678%-725750.000-52%1235750.000-223%5540000.000-127%7723000.000-120%
Usd Book Value Change Per Share---0.4320.035-1349%-0.191-56%-0.136-69%-0.002-99%-0.059-86%
Usd Book Value Per Share---0.2790.005-5678%-0.133-52%0.227-223%1.016-127%1.289-122%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--11112578.60013418874.475-17%3057574.537+263%9514711.646+17%16096306.892-31%992043058.512-99%
Usd Eps---0.497-0.385-23%-0.474-5%-0.471-5%-0.524+5%-0.460-8%
Usd Free Cash Flow---1618000.000-2030000.000+25%-2236500.000+38%-2277083.333+41%-2507000.000+55%-2201825.000+36%
Usd Free Cash Flow Per Share---0.297-0.372+25%-0.410+38%-0.418+41%-0.460+55%-0.401+35%
Usd Free Cash Flow To Equity Per Share---0.2610.000-1879215175209093632%-0.179-31%-0.137-47%0.010-2758%-0.031-88%
Usd Market Cap13031690.100-6%13849578.60014735624.475-6%5685824.537+144%10183211.646+36%12541256.892+10%985757208.512-99%
Usd Price Per Share2.390-6%2.5402.703-6%1.043+144%1.868+36%2.300+10%2.006+27%
Usd Profit---2712000.000-2097750.000-23%-2584250.000-5%-2567500.000-5%-2858600.000+5%-2820825.000+4%
Usd Revenue----13750.0000%117000.000-100%147416.667-100%147550.000-100%7975.000-100%
Usd Total Gains Per Share---0.4320.035-1349%-0.191-56%-0.136-69%-0.002-99%-0.059-86%
 EOD+2 -6MRQTTM+8 -23YOY+14 -183Y+13 -195Y+14 -1810Y+10 -23

3.3 Fundamental Score

Let's check the fundamental score of Biocardia Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.201
Price to Book Ratio (EOD)Between0-1-8.573
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.293
Current Ratio (MRQ)Greater than10.363
Debt to Asset Ratio (MRQ)Less than11.702
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.252
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Biocardia Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.672
Ma 20Greater thanMa 502.177
Ma 50Greater thanMa 1002.294
Ma 100Greater thanMa 2002.303
OpenGreater thanClose2.358
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Biocardia Inc

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths products. It has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. BioCardia, Inc. is based in Sunnyvale, California.

Fundamental data was last updated by Penke on 2025-07-10 22:01:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biocardia earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biocardia Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-12,727.0%+12,727.0%
TTM-12,727.0%YOY-7,186.0%-5,541.0%
TTM-12,727.0%5Y-7,124.2%-5,602.8%
5Y-7,124.2%10Y-4,516.6%-2,607.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--93.6%+93.6%
TTM-12,727.0%-140.9%-12,586.1%
YOY-7,186.0%-197.6%-6,988.4%
3Y-7,472.6%-248.5%-7,224.1%
5Y-7,124.2%-343.4%-6,780.8%
10Y-4,516.6%-496.2%-4,020.4%
4.3.1.2. Return on Assets

Shows how efficient Biocardia is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • -125.2% Return on Assets means that Biocardia generated $-1.25 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biocardia Inc:

  • The MRQ is -125.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -67.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-125.2%TTM-67.9%-57.3%
TTM-67.9%YOY-69.1%+1.2%
TTM-67.9%5Y-42.9%-25.0%
5Y-42.9%10Y-39.2%-3.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-125.2%-11.6%-113.6%
TTM-67.9%-11.6%-56.3%
YOY-69.1%-11.4%-57.7%
3Y-56.9%-11.8%-45.1%
5Y-42.9%-12.0%-30.9%
10Y-39.2%-13.7%-25.5%
4.3.1.3. Return on Equity

Shows how efficient Biocardia is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • 0.0% Return on Equity means Biocardia generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biocardia Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-84.4%+84.4%
TTM-84.4%YOY-52.4%-32.0%
TTM-84.4%5Y-60.0%-24.4%
5Y-60.0%10Y-57.9%-2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM-84.4%-14.9%-69.5%
YOY-52.4%-14.6%-37.8%
3Y-75.4%-16.8%-58.6%
5Y-60.0%-17.5%-42.5%
10Y-57.9%-19.9%-38.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biocardia Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biocardia is operating .

  • Measures how much profit Biocardia makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biocardia Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-12,741.2%+12,741.2%
TTM-12,741.2%YOY-7,446.5%-5,294.8%
TTM-12,741.2%5Y-7,223.3%-5,518.0%
5Y-7,223.3%10Y-4,574.2%-2,649.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.5%+232.5%
TTM-12,741.2%-250.5%-12,490.7%
YOY-7,446.5%-209.2%-7,237.3%
3Y-7,585.0%-234.1%-7,350.9%
5Y-7,223.3%-346.1%-6,877.2%
10Y-4,574.2%-477.5%-4,096.7%
4.3.2.2. Operating Ratio

Measures how efficient Biocardia is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biocardia Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM136.022-136.022
TTM136.022YOY74.449+61.573
TTM136.0225Y96.065+39.956
5Y96.06510Y60.037+36.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.111-2.111
TTM136.0222.694+133.328
YOY74.4493.096+71.353
3Y88.5923.652+84.940
5Y96.0654.745+91.320
10Y60.0376.614+53.423
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biocardia Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biocardia is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.36 means the company has $0.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biocardia Inc:

  • The MRQ is 0.363. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.915. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.363TTM0.915-0.552
TTM0.915YOY0.659+0.256
TTM0.9155Y2.227-1.312
5Y2.22710Y159.624-157.397
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3633.661-3.298
TTM0.9153.846-2.931
YOY0.6594.140-3.481
3Y1.2294.688-3.459
5Y2.2275.746-3.519
10Y159.6246.147+153.477
4.4.3.2. Quick Ratio

Measures if Biocardia is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • A Quick Ratio of 0.29 means the company can pay off $0.29 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biocardia Inc:

  • The MRQ is 0.293. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.851. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.293TTM0.851-0.558
TTM0.851YOY0.594+0.258
TTM0.8515Y2.153-1.301
5Y2.15310Y200.010-197.857
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2932.848-2.555
TTM0.8513.169-2.318
YOY0.5943.786-3.192
3Y1.1604.311-3.151
5Y2.1535.703-3.550
10Y200.0106.368+193.642
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biocardia Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biocardia assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biocardia to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.70 means that Biocardia assets are financed with 170.2% credit (debt) and the remaining percentage (100% - 170.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biocardia Inc:

  • The MRQ is 1.702. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.179. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.702TTM1.179+0.523
TTM1.179YOY1.327-0.147
TTM1.1795Y0.741+0.438
5Y0.74110Y0.540+0.202
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7020.329+1.373
TTM1.1790.349+0.830
YOY1.3270.331+0.996
3Y1.0180.340+0.678
5Y0.7410.349+0.392
10Y0.5400.379+0.161
4.5.4.2. Debt to Equity Ratio

Measures if Biocardia is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biocardia to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biocardia Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.181-1.181
TTM1.181YOY0.727+0.455
TTM1.1815Y0.886+0.295
5Y0.88610Y0.721+0.165
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM1.1810.437+0.744
YOY0.7270.414+0.313
3Y1.1080.450+0.658
5Y0.8860.464+0.422
10Y0.7210.515+0.206
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biocardia generates.

  • Above 15 is considered overpriced but always compare Biocardia to the Biotechnology industry mean.
  • A PE ratio of -1.28 means the investor is paying $-1.28 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biocardia Inc:

  • The EOD is -1.201. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.277. Based on the earnings, the company is expensive. -2
  • The TTM is -1.870. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.201MRQ-1.277+0.075
MRQ-1.277TTM-1.870+0.593
TTM-1.870YOY-0.493-1.377
TTM-1.8705Y-1.142-0.728
5Y-1.14210Y3,153.921-3,155.064
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.201-2.356+1.155
MRQ-1.277-2.077+0.800
TTM-1.870-2.574+0.704
YOY-0.493-3.760+3.267
3Y-1.067-3.773+2.706
5Y-1.142-6.193+5.051
10Y3,153.921-6.876+3,160.797
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biocardia Inc:

  • The EOD is -2.014. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.140. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.000. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.014MRQ-2.140+0.126
MRQ-2.140TTM-2.000-0.140
TTM-2.000YOY-0.562-1.438
TTM-2.0005Y-1.316-0.684
5Y-1.31610Y155.689-157.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.014-3.246+1.232
MRQ-2.140-2.705+0.565
TTM-2.000-3.704+1.704
YOY-0.562-4.402+3.840
3Y-1.190-5.070+3.880
5Y-1.316-8.477+7.161
10Y155.689-9.305+164.994
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biocardia is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -9.11 means the investor is paying $-9.11 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biocardia Inc:

  • The EOD is -8.573. Based on the equity, the company is expensive. -2
  • The MRQ is -9.112. Based on the equity, the company is expensive. -2
  • The TTM is 0.753. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-8.573MRQ-9.112+0.538
MRQ-9.112TTM0.753-9.864
TTM0.753YOY0.529+0.223
TTM0.7535Y1.454-0.701
5Y1.45410Y71.845-70.391
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.5732.038-10.611
MRQ-9.1121.843-10.955
TTM0.7532.125-1.372
YOY0.5292.442-1.913
3Y1.4012.492-1.091
5Y1.4543.652-2.198
10Y71.8454.311+67.534
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biocardia Inc.

4.8.1. Institutions holding Biocardia Inc

Institutions are holding 4.748% of the shares of Biocardia Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31CM Management, LLC1.47220.19147500050000200
2025-03-31Susquehanna International Group, LLP1.17680599491610736.7387
2025-03-31Geode Capital Management, LLC0.7308037231624420.1504
2025-03-31Brown Advisory Holdings Inc0.69760.000135538355380
2025-03-31Commonwealth Equity Services Inc0.30590.000115583155830
2025-03-31Vanguard Group Inc0.252901288400
2025-03-31UBS Group AG0.090304602-148-3.1158
2025-03-31Morgan Stanley - Brokerage Accounts0.060903105-911-22.6843
2025-03-31Pingora Partners LLC0.02030.002103600
2025-03-31Bank of America Corp0.0081041520.4843
2024-12-31Global Retirement Partners, LLC.0.0081041100
2025-03-31Advisor Group Holdings, Inc.0.001206211.6393
2025-03-31SBI Securities Co Ltd0.000208-7-46.6667
2025-03-31Tower Research Capital LLC000-535-100
2024-12-31Northern Trust Investments N A000-1282-100
2025-03-31JPMorgan Chase & Co000-899-100
Total 4.82530.1936245824+119693+48.7%

4.9.2. Funds holding Biocardia Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Fidelity Extended Market Index0.42220.000221509-206-0.9487
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr0.247601261600
2025-04-30Fidelity Series Total Market Index0.10360528000
2025-04-30Spartan Extended Market Index Pool F0.09380.000247772064.5067
2025-04-30Fidelity Total Market Index0.06350323700
2025-04-30Spartan Total Market Index Pool G0.020501046780293.2331
2025-04-30Fidelity Nasdaq Composite Index0.01890964-1198-55.4117
2025-03-31Northern Trust Extended Eq Market Idx0.0131066800
2025-03-31NT Ext Equity Mkt Idx Fd - L0.0131066800
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.0111056700
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.00870441-8-1.7817
2025-05-31Vanguard U.S. Eq Idx £ Acc0.0053026800
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0031016010.6289
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.003101591590
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.003101591590
2025-05-31State St US Extended Mkt Indx NL Cl C0.002010000
2024-12-31Blackstone Alternative Multi-Strategy I0.000904700
2025-03-31Northern Trust Wilshire 50000.000904600
2025-03-31SSgA U.S. Total Market Index Strategy0.000804212.439
2025-03-31Aptus Impact Series Growth0.00080.00014100
Total 1.03610.000552795-106-0.2%

5.3. Insider Transactions

Insiders are holding 21.661% of the shares of Biocardia Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-30David McclungBUY48192.08
2025-06-30Peter AltmanBUY240962.08
2025-06-30Simon H StertzerBUY722892.08
2025-06-30Andrew Scott BlankBUY722892.08
2025-05-30Peter AltmanBUY1002.21
2025-05-22Peter AltmanBUY7001.89
2025-05-20Peter AltmanBUY16002.08
2025-05-16Peter AltmanBUY3002.43
2025-05-14Peter AltmanBUY1002.99
2025-04-23Bill FacteauBUY131231.91
2025-04-23Peter AltmanBUY262461.91
2025-04-15Peter AltmanBUY1002.14
2025-04-10Peter AltmanBUY3001.99
2025-04-07Peter AltmanBUY5001.96
2025-04-03Peter AltmanBUY12002.24
2025-03-05Simon H StertzerBUY10002.45
2025-03-03Peter AltmanBUY5002.11
2025-03-03Simon H StertzerBUY227532.3
2025-02-07Peter AltmanBUY6002.48
2025-01-29Peter AltmanBUY5002.4
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,166
Total Liabilities3,686
Total Stockholder Equity-1,520
 As reported
Total Liabilities 3,686
Total Stockholder Equity+ -1,520
Total Assets = 2,166

Assets

Total Assets2,166
Total Current Assets1,173
Long-term Assets993
Total Current Assets
Cash And Cash Equivalents 949
Other Current Assets 224
Total Current Assets  (as reported)1,173
Total Current Assets  (calculated)1,173
+/-0
Long-term Assets
Property Plant Equipment 822
Long-term Assets Other 171
Long-term Assets  (as reported)993
Long-term Assets  (calculated)993
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,234
Long-term Liabilities452
Total Stockholder Equity-1,520
Total Current Liabilities
Short-term Debt 398
Accounts payable 818
Other Current Liabilities 1,200
Total Current Liabilities  (as reported)3,234
Total Current Liabilities  (calculated)2,416
+/- 818
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt452
Long-term Liabilities  (as reported)452
Long-term Liabilities  (calculated)452
+/-0
Total Stockholder Equity
Common Stock5
Retained Earnings -162,833
Other Stockholders Equity 161,308
Total Stockholder Equity (as reported)-1,520
Total Stockholder Equity (calculated)-1,520
+/-0
Other
Capital Stock5
Cash and Short Term Investments 949
Common Stock Shares Outstanding 4,636
Liabilities and Stockholders Equity 2,166
Net Debt -99
Net Invested Capital -1,520
Net Working Capital -2,061
Property Plant and Equipment Gross 1,595
Short Long Term Debt Total 850



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-30
> Total Assets 
900
5,200
4,700
4,700
4,600
4,500
4,200
4,100
3,500
3,400
3,200
3,200
2,600
2,400
4,055
7,429
7,588
6,682
6,271
4,187
3,643
3,380
3,119
2,961
2,616
2,580
2,394
2,642
2,484
2,093
1,931
1,706
1,537
1,457
882
897
398
175
152
141
115
102
95
87
1,547
1,444
2,697
2,661
14,230
11,474
10,445
12,420
11,239
15,588
15,089
13,720
5,643
5,435
5,484
14,646
14,001
13,734
13,636
12,940
13,391
13,301
13,275
13,277
13,308
13,328
13,375
13,441
13,488
13,545
13,620
13,697
13,776
13,876
13,948
14,023
19,483
22,082
19,780
17,756
15,860
13,538
10,411
7,661
5,556
6,417
5,157
2,716
10,681
7,678
4,384
13,128
9,502
23,424
23,308
20,218
17,330
15,718
12,840
11,266
9,179
9,793
7,128
6,389
3,747
2,987
2,679
2,890
6,267
3,724
2,166
2,1663,7246,2672,8902,6792,9873,7476,3897,1289,7939,17911,26612,84015,71817,33020,21823,30823,4249,50213,1284,3847,67810,6812,7165,1576,4175,5567,66110,41113,53815,86017,75619,78022,08219,48314,02313,94813,87613,77613,69713,62013,54513,48813,44113,37513,32813,30813,27713,27513,30113,39112,94013,63613,73414,00114,6465,4845,4355,64313,72015,08915,58811,23912,42010,44511,47414,2302,6612,6971,4441,54787951021151411521753988978821,4571,5371,7061,9312,0932,4842,6422,3942,5802,6162,9613,1193,3803,6434,1876,2716,6827,5887,4294,0552,4002,6003,2003,2003,4003,5004,1004,2004,5004,6004,7004,7005,200900
   > Total Current Assets 
500
4,900
4,400
4,500
4,300
4,200
3,900
3,800
3,200
3,100
2,800
2,900
2,200
2,100
3,733
7,107
6,773
5,949
5,581
3,787
3,314
3,075
2,836
2,702
2,378
2,356
2,188
2,455
2,313
1,931
1,787
1,656
1,488
1,407
882
897
398
175
152
141
115
102
95
87
1,547
1,444
2,697
2,661
5,804
4,330
3,126
5,180
3,922
8,601
8,089
6,706
3,837
639
740
14,646
14,001
13,734
13,636
12,940
13,391
13,301
13,275
13,277
13,308
13,328
13,375
13,441
13,488
13,545
13,620
13,697
13,776
13,876
13,948
14,023
19,483
21,917
19,549
17,522
15,643
13,315
10,205
7,443
5,348
6,218
3,528
1,152
9,237
6,378
3,219
12,096
8,590
22,658
22,659
19,741
17,006
13,481
10,661
9,152
7,154
7,864
5,289
4,650
2,116
1,461
1,259
1,573
5,056
2,622
1,173
1,1732,6225,0561,5731,2591,4612,1164,6505,2897,8647,1549,15210,66113,48117,00619,74122,65922,6588,59012,0963,2196,3789,2371,1523,5286,2185,3487,44310,20513,31515,64317,52219,54921,91719,48314,02313,94813,87613,77613,69713,62013,54513,48813,44113,37513,32813,30813,27713,27513,30113,39112,94013,63613,73414,00114,6467406393,8376,7068,0898,6013,9225,1803,1264,3305,8042,6612,6971,4441,54787951021151411521753988978821,4071,4881,6561,7871,9312,3132,4552,1882,3562,3782,7022,8363,0753,3143,7875,5815,9496,7737,1073,7332,1002,2002,9002,8003,1003,2003,8003,9004,2004,3004,5004,4004,900500
       Cash And Cash Equivalents 
0
3,100
1,000
200
300
400
200
1,400
1,200
2,100
1,800
1,800
1,100
900
2,506
5,976
5,568
4,891
4,586
2,558
2,337
2,052
1,869
1,917
1,731
1,679
1,217
1,799
1,654
1,221
1,162
731
967
1,032
840
871
388
153
133
129
108
97
89
82
1,544
1,419
2,680
2,652
4,582
3,095
1,680
3,250
1,607
4,973
3,688
1,665
196
127
241
12,692
12,608
12,678
12,652
12,884
12,823
13,268
13,254
13,269
13,263
13,295
13,322
13,401
13,456
13,509
13,598
13,688
13,726
13,840
13,925
13,872
19,437
21,352
19,032
15,109
13,326
12,689
9,653
6,834
4,820
5,358
2,838
517
8,910
5,585
2,587
11,086
7,392
21,407
21,502
18,543
15,888
12,872
9,930
8,614
6,667
7,363
4,857
4,305
1,835
1,103
949
1,421
4,930
2,371
949
9492,3714,9301,4219491,1031,8354,3054,8577,3636,6678,6149,93012,87215,88818,54321,50221,4077,39211,0862,5875,5858,9105172,8385,3584,8206,8349,65312,68913,32615,10919,03221,35219,43713,87213,92513,84013,72613,68813,59813,50913,45613,40113,32213,29513,26313,26913,25413,26812,82312,88412,65212,67812,60812,6922411271961,6653,6884,9731,6073,2501,6803,0954,5822,6522,6801,4191,5448289971081291331533888718401,0329677311,1621,2211,6541,7991,2171,6791,7311,9171,8692,0522,3372,5584,5864,8915,5685,9762,5069001,1001,8001,8002,1001,2001,4002004003002001,0003,1000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
400
600
1,000
669
601
340
286
369
403
251
327
359
320
298
281
608
181
284
348
307
537
200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,746
0
0
0
0
3,658
0
0
7,114
0
0
0
0
1,796
1,799
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000001,7991,79600007,114003,65800002,74600000000000000000000000000000000000002005373073482841816082812983203593272514033692863406016691,00060040000000000000
       Net Receivables 
400
400
400
400
400
500
1,600
400
400
500
400
600
400
500
476
453
439
389
329
356
313
344
319
381
285
291
279
436
340
278
258
328
275
292
0
0
275
292
0
0
0
0
0
0
0
0
0
0
289
186
265
240
251
307
678
567
486
413
424
460
162
67
24
24
556
0
0
0
0
0
0
0
0
0
0
0
0
0
0
142
0
74
121
142
90
95
127
191
170
274
287
204
103
147
179
733
1,066
850
813
791
760
147
326
211
300
201
153
115
104
63
58
10
10
0
0
00101058631041151532013002113261477607918138501,0667331791471032042872741701911279590142121740142000000000000005562424671624604244134865676783072512402651862890000000000292275002922753282582783404362792912853813193443133563293894394534765004006004005004004001,600500400400400400400
       Other Current Assets 
100
1,400
3,000
3,900
3,600
3,300
2,100
2,000
1,600
500
600
100
100
200
82
77
426
383
298
470
413
353
289
84
64
105
83
40
35
84
60
60
45
83
42
27
10
22
19
12
7
5
6
5
4
25
17
10
78
107
101
114
71
130
53
84
110
99
75
1,494
1,231
989
960
32
12
33
21
8
45
33
53
40
32
36
22
9
50
36
23
9
46
356
252
282
188
340
277
282
224
445
285
426
179
1,707
906
277
132
401
344
407
358
924
810
654
374
300
279
230
177
295
252
142
116
251
224
2242511161422522951772302793003746548109243584073444011322779061,7071794262854452242822773401882822523564692336509223632405333458213312329609891,2311,494759911084531307111410110778101725456571219221027428345606084354083105648428935341347029838342677822001001006005001,6002,0002,1003,3003,6003,9003,0001,400100
   > Long-term Assets 
400
300
300
200
300
300
300
300
300
300
400
300
400
300
322
322
815
733
690
401
330
305
283
260
237
224
206
187
171
162
144
50
50
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,426
7,144
7,319
7,240
7,317
6,987
7,000
7,014
1,806
4,796
4,744
0
0
0
0
0
0
33
0
0
0
33
-1,373
0
0
36
107
-1,829
0
36
-3,557
172
163
165
231
234
217
223
206
218
208
145
1,629
1,564
1,444
1,300
1,165
1,032
912
766
649
477
324
2,237
2,179
2,114
2,025
1,929
1,839
1,739
1,631
1,526
1,420
1,317
1,211
1,102
993
9931,1021,2111,3171,4201,5261,6311,7391,8391,9292,0252,1142,1792,2373244776497669121,0321,1651,3001,4441,5641,629145208218206223217234231165163172-3,557360-1,8291073600-1,37333000330000004,7444,7961,8067,0147,0006,9877,3177,2407,3197,1448,42600000000000000505050144162171187206224237260283305330401690733815322322300400300400300300300300300300200300300400
       Property Plant Equipment 
200
200
200
200
200
300
300
200
300
300
300
300
300
300
290
291
315
356
334
309
287
262
240
217
194
181
163
144
128
119
102
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
366
716
1,057
1,152
1,226
1,228
1,417
1,607
1,774
1,775
1,775
0
0
0
0
0
0
0
0
0
0
66
0
0
0
72
64
0
0
150
0
129
120
111
177
180
163
169
152
164
154
145
1,575
1,510
1,390
1,246
1,111
978
858
712
596
477
324
2,065
2,007
1,943
1,853
1,758
1,667
1,568
1,460
1,355
1,249
1,146
1,040
931
822
8229311,0401,1461,2491,3551,4601,5681,6671,7581,8531,9432,0072,0653244775967128589781,1111,2461,3901,5101,57514515416415216916318017711112012901500064720006600000000001,7751,7751,7741,6071,4171,2281,2261,1521,05771636600000000000000000102119128144163181194217240262287309334356315291290300300300300300300200300300200200200200200
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,690
1,233
1,233
1,233
1,233
1,233
1,233
1,233
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000001,2331,2331,2331,2331,2331,2331,2332,690000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,165
5,003
4,840
4,678
4,515
4,353
4,190
4,027
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000004,0274,1904,3534,5154,6784,8405,0035,165000000000000000000000000000000000000000000000000
       Long-term Assets Other 
200
100
100
100
100
0
0
100
0
0
100
0
100
0
32
31
500
377
356
91
43
43
43
43
43
43
43
43
43
43
42
50
50
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
205
192
189
177
343
173
160
147
32
3,021
4,744
0
0
0
0
0
0
33
0
0
0
33
-1,373
0
0
36
43
-1,829
0
-114
-3,557
43
43
54
54
54
54
54
54
54
54
54
54
54
54
54
54
54
54
54
53
293
0
172
172
171
172
171
172
171
171
171
171
171
171
171
171
17117117117117117117117117217117217117217202935354545454545454545454545454545454544343-3,557-1140-1,829433600-1,37333000330000004,7443,02132147160173343177189192205000000000000005050504243434343434343434343913563775003132010001000010000100100100100200
> Total Liabilities 
1,000
700
500
600
600
500
400
700
900
700
800
1,000
900
700
937
1,163
1,151
1,012
1,054
783
888
782
823
868
788
814
843
963
960
753
793
742
806
784
708
721
241
33
29
25
15
16
21
26
92
9
-2,697
15
933
777
941
1,201
1,028
851
1,789
1,884
1,905
2,156
2,515
270
744
756
711
142
141
12
10
3
3
18
1
1
5
1
2,274
4
83
10
-13,948
9,691
330
1,500
1,430
1,675
2,075
2,413
2,204
1,903
2,612
2,625
4,339
4,952
5,487
5,308
5,667
5,837
5,389
4,248
4,746
4,545
3,918
5,343
5,471
4,532
5,082
4,901
5,228
4,754
4,407
4,590
4,954
4,851
3,514
2,887
3,686
3,6862,8873,5144,8514,9544,5904,4074,7545,2284,9015,0824,5325,4715,3433,9184,5454,7464,2485,3895,8375,6675,3085,4874,9524,3392,6252,6121,9032,2042,4132,0751,6751,4301,5003309,691-13,948108342,2741511183310121411427117567442702,5152,1561,9051,8841,7898511,0281,20194177793315-2,697992262116152529332417217087848067427937539609638438147888688237828887831,0541,0121,1511,1639377009001,0008007009007004005006006005007001,000
   > Total Current Liabilities 
1,000
700
500
600
600
500
500
800
900
700
700
1,000
900
700
937
1,163
1,151
1,012
1,054
783
888
782
823
868
788
814
843
963
960
753
793
742
806
784
708
721
241
33
29
25
15
16
21
26
92
9
0
15
933
777
941
1,201
1,028
851
1,789
1,884
1,905
2,156
2,515
270
744
756
711
142
141
12
10
3
3
18
1
1
5
1
2,274
4
0
10
10
9,691
330
1,444
1,368
1,607
2,000
2,332
2,121
1,819
2,532
2,548
3,323
4,066
4,044
4,003
4,510
4,551
4,320
4,248
4,746
4,545
3,918
3,712
3,913
3,054
3,684
3,585
4,000
3,616
3,330
3,608
4,071
4,071
2,840
2,321
3,234
3,2342,3212,8404,0714,0713,6083,3303,6164,0003,5853,6843,0543,9133,7123,9184,5454,7464,2484,3204,5514,5104,0034,0444,0663,3232,5482,5321,8192,1212,3322,0001,6071,3681,4443309,6911010042,2741511183310121411427117567442702,5152,1561,9051,8841,7898511,0281,201941777933150992262116152529332417217087848067427937539609638438147888688237828887831,0541,0121,1511,1639377009001,0007007009008005005006006005007001,000
       Short-term Debt 
400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
280
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
1,224
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,493
0
478
658
263
7
124
75
43
15
0
938
976
1,016
0
1,096
796
876
1,228
936
632
322
474
281
584
608
315
654
680
642
666
1,040
716
371
385
398
3983853717161,0406666426806543156085842814743226329361,2288767961,09601,0169769380154375124726365847806,493000000000000000000001,2245000000000000000000000000000000280000000000000000000000000000400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
469
0
0
0
0
226
284
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002842260000469000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
100
100
200
200
100
100
100
300
400
300
200
300
300
300
247
406
251
223
194
179
222
211
131
258
119
197
116
278
196
179
195
13
197
189
4
12
2
0
0
8
3
1
1
4
74
9
0
15
933
15
0
0
0
488
0
0
0
1,348
0
830
744
127
0
0
0
0
10
3
0
18
1
1
5
1
407
4
0
542
0
727
1,047
525
291
590
447
902
738
505
1,102
2,548
1,139
1,626
1,112
914
1,108
1,525
1,208
746
850
970
846
507
764
999
887
683
861
686
507
890
1,030
1,447
569
385
818
8183855691,4471,0308905076868616838879997645078469708507461,2081,5251,1089141,1121,6261,1392,5481,1025057389024475902915251,0477270542044071511180310000012774483001,348000488000159331509744113800212418919713195179196278116197119258131211222179194223251406247300300300200300400300100100100200200100100
       Other Current Liabilities 
500
600
300
400
500
400
400
500
500
400
500
700
600
400
690
756
901
789
591
319
332
282
364
308
366
346
444
417
499
376
384
556
375
383
705
709
239
33
29
17
13
16
20
22
18
0
0
0
-933
777
941
1,201
1,028
363
1,789
1,884
1,905
308
1,291
270
744
73
711
142
141
12
-10
-3
3
18
1
1
5
1
1,867
4
0
-532
0
2,471
-717
478
1,077
864
669
663
654
635
1,430
77
1,246
1,464
1,225
732
1,617
2,390
2,209
2,221
2,709
2,370
1,864
2,907
1,920
1,471
2,634
1,622
3,190
3,119
2,181
2,052
2,135
1,908
1,900
1,019
1,200
1,2001,0191,9001,9082,1352,0522,1813,1193,1901,6222,6341,4711,9202,9071,8642,3702,7092,2212,2092,3901,6177321,2251,4641,246771,4306356546636698641,077478-7172,4710-532041,8671511183-3-1012141142711737442701,2913081,9051,8841,7893631,0281,201941777-9330001822201613172933239709705383375556384376499417444346366308364282332319591789901756690400600700500400500500400400500400300600500
   > Long-term Liabilities 
500
100
200
200
100
100
-100
-100
400
300
100
300
300
300
247
406
251
223
464
463
556
500
460
561
422
469
399
547
460
378
409
415
431
401
4
0
2
0
0
8
3
1
1
4
74
9
0
15
933
15
0
0
0
0
0
0
0
1,799
1,224
0
0
127
0
0
0
0
10
3
0
0
0
0
0
0
0
0
83
0
0
0
0
56
62
68
75
81
83
84
80
0
1,016
886
1,443
1,305
1,157
1,286
1,069
2,748
3,198
3,398
2,589
1,631
1,558
1,478
1,398
1,316
1,228
1,138
1,077
982
883
780
674
566
452
4525666747808839821,0771,1381,2281,3161,3981,4781,5581,6312,5893,3983,1982,7481,0691,2861,1571,3051,4438861,01608084838175686256000083000000003100000127001,2241,7990000000159331509744113800204401431415409378460547399469422561460500556463464223251406247300300300100300400-100-100100100200200100500
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
0
0
0
31
0
0
0
0
0
0
0
56
62
68
75
81
83
84
80
77
0
0
691
691
689
689
683
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000006836896896916910077808483817568625600000003100031000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56
62
68
75
81
83
0
0
0
0
0
0
0
689
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000006890000000838175686256000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-100
4,500
4,200
4,100
4,000
4,000
3,800
3,400
2,600
2,700
2,400
2,200
1,700
1,700
3,118
6,266
6,436
5,670
5,216
3,405
2,755
2,598
2,296
2,093
1,827
1,766
1,551
1,679
1,524
1,340
1,137
964
732
673
174
177
157
142
123
117
100
86
75
61
1,455
1,435
2,697
2,646
13,297
10,697
9,504
11,219
10,211
14,737
13,300
11,836
3,738
3,279
2,969
14,376
13,257
12,978
12,925
12,798
13,250
13,289
13,265
13,274
13,305
13,310
13,374
13,440
13,483
13,544
13,620
13,693
13,693
13,866
13,948
14,023
19,153
20,582
18,350
16,081
13,785
11,125
8,207
5,758
2,944
3,792
818
-2,236
5,194
2,370
-1,283
7,291
4,113
19,176
18,562
15,673
13,412
10,375
7,369
6,734
4,097
4,892
1,900
1,635
-660
-1,603
-2,275
-1,961
2,753
837
-1,520
-1,5208372,753-1,961-2,275-1,603-6601,6351,9004,8924,0976,7347,36910,37513,41215,67318,56219,1764,1137,291-1,2832,3705,194-2,2368183,7922,9445,7588,20711,12513,78516,08118,35020,58219,15314,02313,94813,86613,69313,69313,62013,54413,48313,44013,37413,31013,30513,27413,26513,28913,25012,79812,92512,97813,25714,3762,9693,2793,73811,83613,30014,73710,21111,2199,50410,69713,2972,6462,6971,4351,4556175861001171231421571771746737329641,1371,3401,5241,6791,5511,7661,8272,0932,2962,5982,7553,4055,2165,6706,4366,2663,1181,7001,7002,2002,4002,7002,6003,4003,8004,0004,0004,1004,2004,500-100
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
4
4
4
4
1
1
1
1
1
1
1
1
1
1
9
9
9
9
9
9
10
10
10
10
10
10
10
10
10
55
55
11
11
203
203
203
203
706
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
230
231
458
458
458
38
38
38
38
38
43
44
44
46
7
7
12
12
16
17
17
17
17
17
18
18
20
20
22
22
24
27
2
5
5
5
555227242222202018181717171717161212774644444338383838384584584582312302302302302302302302302302302302302302302302302302302302302302302302302302302307062032032032031111555510101010101010101099999911111111114444300000000000000
   Retained Earnings -162,833-160,121-157,825-156,088-154,442-152,175-150,103-147,529-144,105-140,604-137,576-134,519-132,022-128,697-125,236-122,530-119,043-116,074-113,085-109,237-105,664-101,070-97,568-93,776-90,026-86,361-82,719-79,175-75,988-72,450-68,964-65,963-63,018-60,142-6,854-11,975-12,050-12,132-12,305-12,305-12,378-12,454-12,515-12,558-12,624-12,688-12,693-12,723-12,732-12,707-12,745-13,196-13,067-13,012-12,727-11,599-22,995-22,674-22,215-14,102-12,620-11,165-9,855-8,650-7,311-6,087-3,809-10,359-10,308-10,236-10,190-10,098-10,080-10,065-10,047-10,022-10,012-9,989-9,969-9,929-9,880-9,357-9,297-9,117-8,957-8,745-8,505-8,394-8,451-8,238-8,124-7,915-7,717-7,429-7,159-6,687-6,459-5,908-4,882-4,327-3,583-3,200-3,100-2,700-2,400-2,300-2,200-1,400-1,200-1,000-900-700-300-100-100
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,795
25,804
0
0
0
0
0
0
0
0
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,768
25,776
80,266
80,910
81,586
82,711
83,537
84,157
84,895
85,625
90,110
90,800
91,496
102,716
103,433
104,374
116,516
117,186
135,234
137,588
138,186
0
0
0
0
0
0
145,985
0
0
0
0
0
0
0
0
00000000145,985000000138,186137,588135,234117,186116,516104,374103,433102,71691,49690,80090,11085,62584,89584,15783,53782,71181,58680,91080,26625,77625,76825,76825,76825,76825,76825,76825,76825,76825,76825,76825,7680000000025,80425,79500000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
4,700
4,600
4,900
5,000
5,100
5,200
4,900
5,100
5,300
5,100
4,800
4,800
4,900
4,982
8,940
9,857
10,080
10,101
10,097
10,035
10,026
10,027
10,027
10,028
10,028
10,028
10,028
10,028
10,020
10,020
10,020
10,020
10,020
10,045
10,096
10,116
10,121
10,125
10,129
10,137
10,141
10,145
10,149
11,615
11,699
12,994
12,994
16,953
16,581
16,612
19,666
19,360
25,672
25,690
25,708
25,723
25,723
25,734
25,745
25,754
25,760
25,762
25,764
25,765
25,766
25,767
25,767
25,768
25,768
26,081
25,768
25,768
25,768
25,768
25,998
25,768
25,768
25,998
25,768
-20,254
80,686
80,910
81,586
83,539
84,295
84,936
85,697
85,625
0
90,800
91,496
102,716
0
104,374
116,516
117,186
135,234
137,588
138,186
138,631
139,055
139,374
141,235
141,655
145,476
145,985
149,142
149,421
150,548
152,140
154,125
160,573
160,953
161,308
161,308160,953160,573154,125152,140150,548149,421149,142145,985145,476141,655141,235139,374139,055138,631138,186137,588135,234117,186116,516104,3740102,71691,49690,800085,62585,69784,93684,29583,53981,58680,91080,686-20,25425,76825,99825,76825,76825,99825,76825,76825,76825,76826,08125,76825,76825,76725,76725,76625,76525,76425,76225,76025,75425,74525,73425,72325,72325,70825,69025,67219,36019,66616,61216,58116,95312,99412,99411,69911,61510,14910,14510,14110,13710,12910,12510,12110,11610,09610,04510,02010,02010,02010,02010,02010,02810,02810,02810,02810,02810,02710,02710,02610,03510,09710,10110,0809,8578,9404,9824,9004,8004,8005,1005,3005,1004,9005,2005,1005,0004,9004,6004,7000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue58
Cost of Revenue-430
Gross Profit-4,329-372
 
Operating Income (+$)
Gross Profit-4,329
Operating Expense-8,059
Operating Income-8,001-12,388
 
Operating Expense (+$)
Research Development4,387
Selling General Administrative3,672
Selling And Marketing Expenses0
Operating Expense8,0598,059
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-8,001
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,946-8,056
EBIT - interestExpense = -8,001
-15,892
-7,946
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-8,001-7,946
Earnings Before Interest and Taxes (EBITDA)-7,934
 
After tax Income (+$)
Income Before Tax-7,946
Tax Provision-0
Net Income From Continuing Ops-7,946-7,946
Net Income-7,946
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,059
Total Other Income/Expenses Net550
 

Technical Analysis of Biocardia
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biocardia. The general trend of Biocardia is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biocardia's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biocardia Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biocardia Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.4 < 2.45 < 2.92.

The bearish price targets are: 2.36 > 1.95 > 1.95.

Know someone who trades $BCDA? Share this with them.👇

Biocardia Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biocardia Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biocardia Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biocardia Inc. The current macd is 0.02755067.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biocardia price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biocardia. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biocardia price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biocardia Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiocardia Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biocardia Inc. The current adx is 15.29.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biocardia shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Biocardia Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biocardia Inc. The current sar is 1.979312.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Biocardia Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biocardia Inc. The current rsi is 58.67. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Biocardia Inc Daily Relative Strength Index (RSI) ChartBiocardia Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biocardia Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biocardia price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biocardia Inc Daily Stochastic Oscillator ChartBiocardia Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biocardia Inc. The current cci is 133.95.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Biocardia Inc Daily Commodity Channel Index (CCI) ChartBiocardia Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biocardia Inc. The current cmo is 28.58.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Biocardia Inc Daily Chande Momentum Oscillator (CMO) ChartBiocardia Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biocardia Inc. The current willr is -12.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Biocardia Inc Daily Williams %R ChartBiocardia Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biocardia Inc.

Biocardia Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biocardia Inc. The current atr is 0.16677929.

Biocardia Inc Daily Average True Range (ATR) ChartBiocardia Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biocardia Inc. The current obv is 28,611,784.

Biocardia Inc Daily On-Balance Volume (OBV) ChartBiocardia Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biocardia Inc. The current mfi is 86.79.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Biocardia Inc Daily Money Flow Index (MFI) ChartBiocardia Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biocardia Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Biocardia Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biocardia Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.672
Ma 20Greater thanMa 502.177
Ma 50Greater thanMa 1002.294
Ma 100Greater thanMa 2002.303
OpenGreater thanClose2.358
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biocardia with someone you think should read this too:
  • Are you bullish or bearish on Biocardia? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biocardia? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biocardia Inc

I send you an email if I find something interesting about Biocardia Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biocardia Inc.

Receive notifications about Biocardia Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.